Beijing Tong Ren Tang Chinese Medicine Company Limited announced that with the sustained outbreak of coronavirus disease (COVID-19) in the first half of 2020, a series of precautionary and control measures has been implemented in the Mainland China, Hong Kong and Macao and many countries globally, the business of the Group has been greatly affected. The global epidemic spreading together with the sustained global economic recession have materially affected the Group's business performance in the first half of 2020. The board of directors (the "Board") of the Company expects the revenue and profit after tax of the Group for the six months ended 30 June 2020 may decrease by 30% to 40% as compared to the corresponding period in 2019.